Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments.
about
Amino-terminal polypeptides of vimentin are responsible for the changes in nuclear architecture associated with human immunodeficiency virus type 1 protease activity in tissue culture cellsAn assembly domain of the Rous sarcoma virus Gag protein required late in buddingCleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosinCytoskeletal proteins inside human immunodeficiency virus type 1 virionsInhibitors of human immunodeficiency virus type 1 zinc fingers prevent normal processing of gag precursors and result in the release of noninfectious virus particlesToxin-based therapeutic approachesSingle amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle productionCasp8p41: The Protean Mediator of Death in CD4 T-cells that Replicate HIVHIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentationDMP 323, a nonpeptide cyclic urea inhibitor of human immunodeficiency virus (HIV) protease, specifically and persistently blocks intracellular processing of HIV gag polyproteinSelection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral proteaseInhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteinsHIV-1 nucleocapsid and ESCRT-component Tsg101 interplay prevents HIV from turning into a DNA-containing virus.Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles.Macrophages archive HIV-1 virions for dissemination in trans.Mutational analysis of the hydrophobic tail of the human immunodeficiency virus type 1 p6(Gag) protein produces a mutant that fails to package its envelope protein.Conserved cysteines of the human immunodeficiency virus type 1 protease are involved in regulation of polyprotein processing and viral maturation of immature virionsPackaging cell lines for simian foamy virus type 1 vectors.Patients with discordant responses to antiretroviral therapy have impaired killing of HIV-infected T cells.Phosphorylation and proteolytic cleavage of gag proteins in budded simian immunodeficiency virus.A bipartite membrane-binding signal in the human immunodeficiency virus type 1 matrix protein is required for the proteolytic processing of Gag precursors in a cell type-dependent mannerIdentification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.Kinetic analysis of human immunodeficiency virus type 1 assembly reveals the presence of sequential intermediates.The late stage of human immunodeficiency virus type 1 assembly is an energy-dependent process.Heterologous late-domain sequences have various abilities to promote budding of human immunodeficiency virus type 1.HIV-1 protease cleaves eukaryotic initiation factor 4G and inhibits cap-dependent translation.Activation of the Mason-Pfizer monkey virus protease within immature capsids in vitroCalmodulin disrupts the structure of the HIV-1 MA proteinRedundant roles for nucleocapsid and matrix RNA-binding sequences in human immunodeficiency virus type 1 assembly.Highly conserved serine residue 40 in HIV-1 p6 regulates capsid processing and virus core assembly.Elimination of protease activity restores efficient virion production to a human immunodeficiency virus type 1 nucleocapsid deletion mutant.Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression.Removal of human immunodeficiency virus type 1 (HIV-1) protease inhibitors from preparations of immature HIV-1 virions does not result in an increase in infectivity or the appearance of mature morphologyThe HIV-1-specific protein Casp8p41 induces death of infected cells through Bax/Bak.Inhibition of human immunodeficiency virus envelope glycoprotein- mediated single cell lysis by low-molecular-weight antagonists of viral entry.Human immunodeficiency virus type 1 virions composed of unprocessed Gag and Gag-Pol precursors are capable of reverse transcribing viral genomic RNA.A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particlesDefining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivityInhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particlesHuman immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo
P2860
Q24599011-5D3E1EE1-2F6B-4CF6-99BF-325E029EC21DQ24645654-E7F5A392-C551-4017-B2B6-DC6265BB4370Q24676673-40DD53DC-2A1A-4DC9-95C8-58D2B90774CBQ24680106-36F5E6F2-DCFF-4BE2-AC97-3CF985CD2C88Q24681117-9BC47604-E614-4344-991A-7A70246CD255Q27013664-DCB9D876-703F-4B6E-8016-76AFBDDD5D26Q27485930-08266FF0-62D8-4ADE-9791-BC816E066AB5Q28069817-39706280-737F-4251-9FB7-365B5EF70A9BQ28211642-B6DA50D0-70E3-4E02-B5F2-10A72ED1AFC3Q28369100-4DB2FB50-6797-4C93-B939-53D39944193BQ28378274-71AEBE10-C7F0-4015-B58A-E0C4C7D5F5AEQ28379468-B0E0A270-A30B-4AA1-BFB1-3A507741BC3DQ30369511-9F62F7D4-9D63-468B-BC04-FA8FA6161AB3Q30452154-5A0E165C-6571-436E-8658-C45A9A2B9CD7Q33215934-CEBD8C32-D7EE-4FA6-B317-93A0647805A6Q33638655-0EEE9730-28FC-41CD-BD4B-E3B6CE2617B9Q33640739-1C4512F8-B604-4F16-A01F-E3936861B1EFQ33651255-B863FC43-22D7-45A9-9244-4845348F630EQ33760825-FF75E485-9C36-417D-8C7B-EADB1B9E66DBQ33781019-9903C477-721B-466F-90D5-B78E9CD69E26Q33785367-E0C381E7-65EB-4D55-B52B-0BFF931FA38CQ33804495-F0CB9382-9562-453B-833B-2651797673F7Q33806395-F4ACA226-F2B2-4396-B257-1728E4CF9F28Q33841842-5A75AADD-604B-4B30-9DA7-622198891C08Q33884090-121F0604-6789-46C6-8338-0DC0D8B05606Q33948995-7EAAAB23-2F3E-4265-9D97-E3709EC430F4Q33952099-1102BC76-8A3A-4A8C-85DF-2292794D56BCQ33987311-E5CCD23E-6DE8-4898-975F-C3082E8B345DQ34123957-02BE1989-91A3-485B-B110-2F4EF0BB7D69Q34626162-D542D799-6896-4E34-A3D1-233BFBCE9ADBQ34976852-0C2DF2A2-1FCE-4149-9F85-DC87546C8369Q35020604-59EDCAAB-A277-4681-BC54-AD5B9DD6CA6EQ35135963-1E036C48-5301-46E6-95F7-64367F72787DQ35140447-714BE7FA-E6AE-4043-844C-EC1F886FCA8EQ35635009-428B485F-19C6-41C6-907B-10BC11C65BD4Q35823493-8207C9E0-71B0-4C12-A8A8-6FFA840089F0Q35826475-A11F573D-BB5F-41E7-9C5B-1BD414E44F4CQ35838533-6BEB143D-0774-415D-A6D6-471EBF4E057FQ35860937-EF7E4BE5-FA72-4B87-B798-BE691B33BCCFQ35914355-B4118F63-E00D-4BDB-A1A1-2AA7846B1DA3
P2860
Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments.
description
1991 nî lūn-bûn
@nan
1991 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Human immunodeficiency virus t ...... in two cellular compartments.
@ast
Human immunodeficiency virus t ...... in two cellular compartments.
@en
Human immunodeficiency virus t ...... in two cellular compartments.
@nl
type
label
Human immunodeficiency virus t ...... in two cellular compartments.
@ast
Human immunodeficiency virus t ...... in two cellular compartments.
@en
Human immunodeficiency virus t ...... in two cellular compartments.
@nl
prefLabel
Human immunodeficiency virus t ...... in two cellular compartments.
@ast
Human immunodeficiency virus t ...... in two cellular compartments.
@en
Human immunodeficiency virus t ...... in two cellular compartments.
@nl
P2860
P356
P1476
Human immunodeficiency virus t ...... in two cellular compartments.
@en
P2093
A H Kaplan
R Swanstrom
P2860
P304
P356
10.1073/PNAS.88.10.4528
P407
P577
1991-05-01T00:00:00Z